{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:49Z","timestamp":1791357109154,"version":"4.3.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/01.pap.0000249958.96498.ce","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T04:37:16Z","timestamp":1179722236000},"page":"314-318","source":"Crossref","is-referenced-by-count":31,"title":["Clozapine-Resistant Psychosis, Smoking, and Caffeine: Managing the Neglected Effects of Substances That Our Patients Consume Every Day"],"prefix":"10.1097","volume":"14","author":[{"given":"Luiz","family":"Dratcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Grandison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle","family":"Bamidele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodini","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 31","key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/S0007125000298565","article-title":"Factors which can make patients difficult to treat.","volume":"169","author":"Kane","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"Suppl B","key":"R2-18-20210202","first-page":"47","article-title":"An overview of the mechanism of action of clozapine.","volume":"55","author":"Meltzer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R3-18-20210202","first-page":"130","article-title":"Definition, evaluation, and management of treatment refractory mania.","volume":"35","author":"Keck","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1017\/S0790966700006182","article-title":"Substance use history taking by trainee psychiatrists: there is a tide in the affairs of men.","volume":"18","author":"Grandison","year":"2001","journal-title":"Irish J Psychological Med"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric outpatients.","volume":"143","author":"Hughes","year":"1986","journal-title":"Am J Psychiatry"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/oxfordjournals.schbul.a007143","article-title":"Caffeine intake in outpatients with schizophrenia.","volume":"30","author":"Gurpegui","year":"2004","journal-title":"Schizophr Bull"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(96)00435-2","article-title":"The role of dopamine in the behavioral effects of caffeine in animals and humans.","volume":"57","author":"Garrett","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 1","key":"R9-18-20210202","first-page":"25","article-title":"Defining and improving response to treatment in patients with bipolar disorder.","volume":"65","author":"Keck","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-0327(97)00160-2","article-title":"Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics.","volume":"48","author":"Frye","year":"1998","journal-title":"J Affect Disord"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002130050028","article-title":"Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.","volume":"148","author":"Spina","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003088-199500291-00005","article-title":"Drug interactions and the cytochrome P450 system: the role of cytochrome P450 1A2.","volume":"29","author":"Brosen","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.","volume":"24","author":"Rostami-Hodjegan","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clpt.2004.04.003","article-title":"Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.","volume":"76","author":"Faber","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R16-18-20210202","first-page":"580","article-title":"Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.","volume":"1","author":"Skogh","year":"1992","journal-title":"Ther Drug Monit"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00004714-200108000-00007","article-title":"CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady state concentration in patients with schizophrenia.","volume":"21","author":"Ozdemir","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2125.2000.00111.x","article-title":"Effect of caffeine on clozapine pharmacokinetics in healthy volunteers.","volume":"49","author":"Hagg","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-3223(90)90429-6","article-title":"Effects of the acute administration of caffeine in patients with schizophrenia.","volume":"28","author":"Lucas","year":"1990","journal-title":"Biol Psychiatry"},{"key":"R20-18-20210202","first-page":"CD001357","article-title":"Amisulpride for schizophrenia.","volume":"2","author":"Mota","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v66n0505","article-title":"An open-label study of amisulpride in the treatment of mania.","volume":"66","author":"Vieta","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0447.2004.00356.x","article-title":"Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.","volume":"110","author":"Munro","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euroneuro.2003.09.001","article-title":"Plasma amisulpride levels in schizophrenia or schizoaffective disorder.","volume":"14","author":"Bergemann","year":"2004","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-200705000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:39:58Z","timestamp":1786034398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-200705000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pap.0000249958.96498.ce","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}